Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 2 of 3: Mean cell count and mean normalized growth rate inhibition values across all replicates. - Dataset (ID:20257)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | Methotrexate | 0.31623 | uM | 3 | 156.25 | 80.34 | 104.00 | 93.25 | 1.1168 | 3.8576 |
| SK-BR-3 | Taxol | 0.01 | uM | 3 | 156.25 | 80.34 | 77.00 | 93.25 | 0.8352 | 0.8351 |
| SK-BR-3 | Omipalisib | 1 | uM | 3 | 156.25 | 80.34 | 66.00 | 93.25 | 0.7160 | -0.5521 |
| SK-BR-3 | Methotrexate | 0.1 | uM | 3 | 156.25 | 80.34 | 100.33 | 93.25 | 1.0849 | 4.8964 |
| SK-BR-3 | Taxol | 0.00016596 | uM | 3 | 156.25 | 80.34 | 131.33 | 93.25 | 1.4055 | 19.8785 |
| SK-BR-3 | Taxol | 0.0031623 | uM | 3 | 156.25 | 80.34 | 93.67 | 93.25 | 1.0080 | 1.4189 |
| SK-BR-3 | Omipalisib | 0.01 | uM | 3 | 156.25 | 80.34 | 74.33 | 93.25 | 0.8024 | -0.2772 |
| SK-BR-3 | Omipalisib | 0.31623 | uM | 3 | 156.25 | 80.34 | 84.67 | 93.25 | 0.9077 | 0.3865 |
| SK-BR-3 | Methotrexate | 0.0016596 | uM | 3 | 156.25 | 80.34 | 85.33 | 93.25 | 0.9227 | 1.0745 |
| SK-BR-3 | Methotrexate | 0.031623 | uM | 3 | 156.25 | 80.34 | 103.00 | 93.25 | 1.0859 | 1.8693 |
| SK-BR-3 | Methotrexate | 3.1623 | uM | 3 | 156.25 | 80.34 | 111.67 | 93.25 | 1.1993 | 5.0966 |
| SK-BR-3 | Methotrexate | 10 | uM | 3 | 156.25 | 80.34 | 95.00 | 93.25 | 1.0279 | 3.3704 |
| SK-BR-3 | Taxol | 0.00033113 | uM | 3 | 156.25 | 80.34 | 119.67 | 93.25 | 1.2945 | 16.4059 |
| SK-BR-3 | Taxol | 0.001 | uM | 3 | 156.25 | 80.34 | 94.00 | 93.25 | 1.0043 | 1.0973 |
| SK-BR-3 | Omipalisib | 0.0016596 | uM | 3 | 156.25 | 80.34 | 101.33 | 93.25 | 1.0843 | 6.0200 |
| SK-BR-3 | Omipalisib | 0.0033113 | uM | 3 | 156.25 | 80.34 | 92.00 | 93.25 | 0.9915 | 1.4225 |
| SK-BR-3 | Omipalisib | 0.031623 | uM | 3 | 156.25 | 80.34 | 93.00 | 93.25 | 0.9886 | 0.7844 |
| SK-BR-3 | Omipalisib | 0.1 | uM | 3 | 156.25 | 80.34 | 70.33 | 93.25 | 0.7545 | -0.2677 |
| SK-BR-3 | Omipalisib | 3.1623 | uM | 3 | 156.25 | 80.34 | 63.00 | 93.25 | 0.6731 | -0.6601 |
| SK-BR-3 | Omipalisib | 10 | uM | 3 | 156.25 | 80.34 | 66.67 | 93.25 | 0.7142 | -0.6050 |
| SK-BR-3 | Methotrexate | 0.0033113 | uM | 3 | 156.25 | 80.34 | 110.67 | 93.25 | 1.1955 | 8.8225 |
| SK-BR-3 | Methotrexate | 0.01 | uM | 3 | 156.25 | 80.34 | 97.00 | 93.25 | 1.0394 | 1.4760 |
| SK-BR-3 | Methotrexate | 1 | uM | 3 | 156.25 | 80.34 | 101.00 | 93.25 | 1.0790 | 3.1935 |
| SK-BR-3 | Taxol | 0.1 | uM | 3 | 156.25 | 80.34 | 88.00 | 93.25 | 0.9485 | 0.9690 |
| SK-BR-3 | Taxol | 0.031623 | uM | 3 | 156.25 | 80.34 | 85.00 | 93.25 | 0.9131 | 0.3236 |